相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial
Francis Couturaud et al.
HAEMATOLOGICA (2019)
Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function
Lucia Mazzolai et al.
EUROPEAN HEART JOURNAL (2018)
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
J. I. Weitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis
Faizan Khan et al.
BMJ OPEN (2017)
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study
Marc A. Rodger et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study
Marc A. Rodger et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)
A. I. Franco Moreno et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH
C. Kearon et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study
P. A. Kyrle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort
Marc A. Rodger et al.
THROMBOSIS RESEARCH (2016)
D-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy A Cohort Study
Clive Kearon et al.
ANNALS OF INTERNAL MEDICINE (2015)
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism The PADIS-PE Randomized Clinical Trial
Francis Couturaud et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Heterogeneity in Meta-analysis of FDG-PET Studies to Diagnose Lung Cancer
Edward J. Mills et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
Stavros V. Konstantinides et al.
EUROPEAN HEART JOURNAL (2014)
Apixaban for Extended Treatment of Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
Sam Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
Lana A. Castellucci et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
Timothy A. Brighton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Aspirin for Preventing the Recurrence of Venous Thromboembolism
Cecilia Becattini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Mortality and recurrence after treatment of VTE: Long term follow-up of patients with good life-expectancy
Marianne S. Andresen et al.
THROMBOSIS RESEARCH (2011)
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials
Florent Boutitie et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
James Douketis et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism
Marc Carrier et al.
ANNALS OF INTERNAL MEDICINE (2010)
Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor A Systematic Review
Alfonso Iorio et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism
M. J. Kovacs et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
Rupert Bauersachs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis
Paolo Prandoni et al.
ANNALS OF INTERNAL MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
Marc A. Rodger et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial
A. Campbell et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
Paolo Prandoni et al.
HAEMATOLOGICA (2007)
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Duration of anticoagulation following venous thrombolembolism - A meta-analysis
D Ost et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism
S Eichinger et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran
S Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study
T Baglin et al.
LANCET (2003)
Extended oral anticoagulant therapy after a first episode of pulmonary embolism
G Agnelli et al.
ANNALS OF INTERNAL MEDICINE (2003)
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis.
G Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
